fructose 2,6-diphosphate has been researched along with Lymph Node Metastasis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ke, H; Li, X; Liu, J; Liu, Y; Qian, L; Tian, W; Yao, C; Zhang, J | 1 |
Chesney, J; Clem, AL; Clem, BF; Imbert-Fernandez, Y; Kerr, DA; Lanceta, L; O'Neal, J; Spaulding, R; Telang, S | 1 |
2 other study(ies) available for fructose 2,6-diphosphate and Lymph Node Metastasis
Article | Year |
---|---|
Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
Topics: A549 Cells; Adenocarcinoma; Adenocarcinoma of Lung; Adult; Aged; Aged, 80 and over; Apoptosis; Biomarkers, Tumor; Blotting, Western; Cell Proliferation; Female; Fructosediphosphates; Glucose; Glycolysis; Humans; Ki-67 Antigen; Lactic Acid; Lung Neoplasms; Lymphatic Metastasis; Male; Middle Aged; Neoplasm Metastasis; Phosphofructokinase-2; Pyridines; Quinolines; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Survival Analysis; Tissue Array Analysis | 2018 |
Estradiol stimulates glucose metabolism via 6-phosphofructo-2-kinase (PFKFB3).
Topics: Apoptosis; Biological Transport; Breast Neoplasms; Cell Survival; Enzyme Inhibitors; Estradiol; Estrogen Receptor alpha; Fructosediphosphates; Fulvestrant; Gene Expression Regulation, Neoplastic; Glucose; Glycolysis; Humans; Lymphatic Metastasis; MCF-7 Cells; Phosphofructokinase-2; Response Elements | 2014 |